Prognostic factors for gastric cancer after curative gastrectomy

Abstract

fluoropyrimidines, platinum agents, and taxanes. Among them, one patient achieved confirmed partial response, and five pts showed stable disease. The most common treatment-related adverse events (!20% of pts) were rash (60%), anemia (30%), neutropenia (30%), thrombocytopenia (20%), and decreased appetite (20%). The second stage is ongoing. Conclusion: TAS-114 with S-1 showed a preliminary efficacy signal with acceptable safety profiles for heavily pretreated pts with AGC, which would be further confirmed in the ongoing study. P À 071 Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network lysis for the literature of past 20 years